NCT02316197 2020-04-28Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic LeukemiaMerck KGaA, Darmstadt, GermanyPhase 1 Completed31 enrolled